'Like Insider Trading' | GenomeWeb

One part of reading grant proposals Proflife Substance particularly enjoys is that it makes him think about his own work differently. But, he says, "herein lies a dilemma with all reviewing — determining where the line is between stimulating independent thought and leaning on someone else's ideas."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.